BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12891630)

  • 1. Microarray analysis of xenograft-derived cancer cell lines representing multiple experimental models of human prostate cancer.
    Glinsky GV; Krones-Herzig A; Glinskii AB; Gebauer G
    Mol Carcinog; 2003 Aug; 37(4):209-21. PubMed ID: 12891630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
    Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
    Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of genes associated with tumor progression using microarrays.
    Gebauer G; Krones-Herzig A; Glinskii AB; Glinsky GV
    Anticancer Res; 2005; 25(3A):1477-82. PubMed ID: 16033048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
    Chaib H; MacDonald JW; Vessella RL; Washburn JG; Quinn JE; Odman A; Rubin MA; Macoska JA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):306-13. PubMed ID: 12759929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
    Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
    Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events.
    Sirotnak FM; She Y; Khokhar NZ; Hayes P; Gerald W; Scher HI
    Mol Carcinog; 2004 Nov; 41(3):150-63. PubMed ID: 15390081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines.
    Gu Y; Li H; Miki J; Kim KH; Furusato B; Sesterhenn IA; Chu WS; McLeod DG; Srivastava S; Ewing CM; Isaacs WB; Rhim JS
    Exp Cell Res; 2006 Apr; 312(6):831-43. PubMed ID: 16413016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
    Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
    Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TRPS1 transcription factor: androgenic regulation in prostate cancer and high expression in breast cancer.
    Chang GT; Jhamai M; van Weerden WM; Jenster G; Brinkmann AO
    Endocr Relat Cancer; 2004 Dec; 11(4):815-22. PubMed ID: 15613454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genotypic analysis of human prostate cancer cell lines and sublines derived from metastases after orthotopic implantation in nude mice.
    Lensch R; Götz C; Andres C; Bex A; Lehmann J; Zwergel T; Unteregger G; Kamradt J; Stoeckle M; Wullich B
    Int J Oncol; 2002 Oct; 21(4):695-706. PubMed ID: 12239607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the androgen receptor pathway during progression of prostate cancer.
    Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G
    Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
    Khanim FL; Gommersall LM; Wood VH; Smith KL; Montalvo L; O'Neill LP; Xu Y; Peehl DM; Stewart PM; Turner BM; Campbell MJ
    Oncogene; 2004 Sep; 23(40):6712-25. PubMed ID: 15300237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.
    Chauchereau A; Al Nakouzi N; Gaudin C; Le Moulec S; Compagno D; Auger N; Bénard J; Opolon P; Rozet F; Validire P; Fromont G; Fizazi K
    Exp Cell Res; 2011 Feb; 317(3):262-75. PubMed ID: 20974126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
    Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
    Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer.
    Eigl BJ; Eggener SE; Baybik J; Ettinger S; Chi KN; Nelson C; Wang Z; Gleave ME
    Clin Cancer Res; 2005 Jul; 11(13):4905-11. PubMed ID: 16000589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CaSm-mediated cellular transformation is associated with altered gene expression and messenger RNA stability.
    Fraser MM; Watson PM; Fraig MM; Kelley JR; Nelson PS; Boylan AM; Cole DJ; Watson DK
    Cancer Res; 2005 Jul; 65(14):6228-36. PubMed ID: 16024624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array.
    Yu YP; Paranjpe S; Nelson J; Finkelstein S; Ren B; Kokkinakis D; Michalopoulos G; Luo JH
    Carcinogenesis; 2005 Feb; 26(2):471-9. PubMed ID: 15485992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
    Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
    Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.